LeonaBio

LeonaBio EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of LeonaBio (LONA) as of Nov 5, 2026 is -0.11. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -0.44 — a change of -74.19% (higher).

EV/FCF

-0.11

YoY

-74.19%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of LeonaBio is 2025 -0.11 . EV/FCF (Enterprise Value to Free Cash Flow) of LeonaBio was 2024 -0.44 . It decreases by -74.19% higher compared to the previous year.

The LeonaBio EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-19.77 USD
Jan 1, 2019
-24.83 USD
Jan 1, 2020
3.44 USD
Jan 1, 2021
3.56 USD
Jan 1, 2022
1.44 USD
Jan 1, 2023
0.53 USD
Jan 1, 2024
-0.44 USD
Jan 1, 2025
-0.11 USD
The LeonaBio EV/FCF history
YEAREV/FCFYoY
-0.11-74.19%
-0.44-183.46%
0.53-63.40%
1.44-59.68%
3.56+3.50%
3.44-113.86%
-24.83+25.63%
-19.77—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LeonaBio Stock analysis

What does LeonaBio do? Athira Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Bothell, Washington, that generates revenue by developing small molecules to restore neuronal health and stop neurodegeneration. The firm utilizes its proprietary ATH platform to target and enhance the activity of a vital neuronal growth factor, creating a pipeline of drugs designed to cross the blood brain barrier for the central nervous system or target the peripheral nervous system. This technology underpins the development of ATH-1017, which is specifically intended for the treatment of neurodegenerative disorders with an initial focus on Alzheimer’s disease. The product aims to improve symptoms in cognitively impaired subjects by enhancing neuronal health and promoting regeneration, serving the medical needs of patients suffering from these conditions. LeonaBio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LeonaBio stock

EV/FCF (Enterprise Value to Free Cash Flow) of LeonaBio is -0.11 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of LeonaBio changed from -0.44 to -0.11, representing a -74.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) LeonaBio since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s LeonaBio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — LeonaBio

All Key Metrics — LeonaBio